Animal Stem Cell Therapy Market Research, 2033
The global animal stem cell therapy market size was valued at $256.0 million in 2023, and is projected to reach $440.0 million by 2033, growing at a CAGR of 5.6% from 2024 to 2033. The animal stem cell therapy market is driven by increasing pet ownership and the rising demand for advanced veterinary treatments, offering non-surgical solutions for chronic conditions. Additionally, technological advancements in biotechnology and supportive regulatory frameworks are accelerating the development and adoption of stem cell therapies in veterinary medicine.
Market Introduction and Definition
Animal stem cell therapy involves the use of stem cells obtained from animals, typically from sources such as bone marrow, adipose tissue, or embryos, to treat various medical conditions or injuries in animals. Stem cells are unique cells with the ability to differentiate into different types of cells in the body, making them valuable for repairing damaged tissues and organs. This therapeutic approach holds promise for treating diseases such as osteoarthritis, spinal cord injuries, and tendon damage in animals, where traditional treatments may have limitations. By harnessing the regenerative potential of stem cells, animal stem cell therapy aims to improve the quality of life for pets, livestock, and other animals, offering a novel avenue for veterinary medicine to address complex health issues effectively.
Key Takeaways
- The Animal stem cell therapy industry study covers 20 countries. The research includes a segment analysis of each country in terms of value ($Million) for the projected period 2023-2033.
- More than 1, 500 product literatures, industry releases, annual reports, and other such documents of major animal stem cell therapy industry participants along with authentic industry journals, trade associations' releases, and government websites have been reviewed for generating high-value industry insights.
- The study integrated high-quality data, professional opinions and analysis, and critical independent perspectives. The research approach is intended to provide a balanced view of global markets and to assist stakeholders in making educated decisions in order to achieve their most ambitious growth objectives.
Key Market Dynamics
The factors responsible for animal stem cell therapy market growth include the increasing pet ownership and the growing demand for advanced veterinary treatments. Pets, such as dogs and cats, are often considered family members, leading to a willingness among pet owners to invest in cutting-edge therapies like stem cell treatments to improve their pets' health outcomes. For example, stem cell therapy is increasingly used to treat osteoarthritis in aging pets, offering a non-surgical option for pain relief and improved mobility.
However, the animal stem cell therapy market size also faces restraints, such as regulatory challenges and ethical considerations surrounding the use of stem cells derived from animals. Regulatory frameworks vary across countries, impacting the adoption and commercialization of stem cell therapies in veterinary medicine. Moreover, ethical debates arise concerning the sourcing and use of embryonic stem cells from animals, posing barriers to widespread acceptance and implementation.
On the other hand, several animal stem cell therapy market opportunity drive innovation and market expansion. Advances in biotechnology and genetic engineering enhance the understanding and application of stem cell therapies in animals. For instance, ongoing research explores the potential of stem cells in treating complex conditions like spinal cord injuries in horses and chronic kidney disease in cats. Additionally, partnerships between academic institutions, biotechnology firms, and veterinary clinics facilitate the development of tailored therapies, expanding treatment options and driving market growth?.
Market Segmentation
The Animal stem cell therapy market is segmented into type, species, end-user and region. On the basis of type, the market is bifurcated into allogenic and autologous. Based on species, the market is divided into dog, cat and horse. Based on end user, the market is divided into veterinary hospitals and research organizations. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Regional/Country Market Outlook
North America held largest animal stem cell therapy market share due to strong emphasis on pet ownership and healthcare standards for companion animals. With pets increasingly considered family members, there is a growing demand for advanced veterinary treatments that offer effective solutions to chronic conditions such as osteoarthritis and ligament injuries. Stem cell therapy provides a promising alternative to traditional treatments, offering potential benefits like pain relief and improved mobility without the need for invasive surgeries.
Moreover, North America boasts a robust infrastructure supporting biotechnology and healthcare innovation, fostering research and development in animal stem cell therapies. This includes collaborations between academic institutions, veterinary clinics, and biotech companies aimed at advancing treatment options and commercializing new therapies. Such partnerships accelerate the translation of scientific discoveries into clinical applications, driving the growth during animal stem cell therapy market forecast.
- In February 2021, USFDA Announces new resource for veterinarians and pet owners interested in clinical field studies of animal cells, tissues, and cell- and tissue-based products.
Industry Trends
- In February 2023, National Institutes of Health grant funds interdisciplinary stem cell research. A team of?Purdue University?scientists led by?Shihuan Kuang?has received a $2.5 million grant from the National Institutes of Health to define the role of lipid droplets in muscle stem cell function, a study with implications in both humans and livestock.
- In August 2023, stem cells used to successfully treat arthritis in gorilla at Budapest zoo in Hungary.
Patent Analysis, By Country, 2018-2024
China witnessed the highest number of patent approvals and applications, due to favorable government policies, new technological advancement ad new product launches in the country. US has 15.7% of the total number of patents, followed by PCT at 11.9% and European Patent Office at 9.4%.
Competitive Landscape
The major animal stem cell therapy market share holder players operating in the Animal stem cell therapy market include Aratana Therapeutics, Inc., VetStem, Inc., Regeneus Ltd., Magellan Stem Cells, PrimeGen Biotech, LLC, Vetbiologics (U.S. Stem Cell, Inc.) , Boehringer Ingelheim (Global stem cell technology) , Cell Therapy Sciences, VETherapy Corporation, MediVet Biologics LLC (Ardent Animal Health. Other players in Animal stem cell therapy market includes Animal Cell Therapies, Inc., Medrego, AniCell Biotech, and so on.
Recent Key Strategies and Developments
- In January 2021, Boehringer?Ingelheim?has entered into a partnership with PetMedix, a UK based research and development stage biopharmaceutical company. Strengthening partnerships to accelerate innovation and growth is now one of the key elements of Boehringer Ingelheim's refocused strategy.
- In July 2019, Elanco Animal Health Incorporated acquired Aratana Therapeutics, a pet therapeutics company focused on developing and commercializing innovative therapeutics for dogs and cats, and developer of the first-of-its-kind canine NSAID for osteoarthritis, Galliprant.
- In March 2019, ?Medrego unveiled a groundbreaking stem cell therapy solution dedicated to enhancing the health and vitality of dogs. Introducing CaniCell, a cutting-edge product specifically designed for the treatment of conditions such as osteoarthritis and various degenerative diseases prevalent in canine companions.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the Animal stem cell therapy market segments, current trends, estimations, and dynamics of the Animal stem cell therapy market analysis from 2023 to 2033 to identify the prevailing Animal stem cell therapy market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the Animal stem cell therapy market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global Animal stem cell therapy market Statistics.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global Animal stem cell therapy market trends, key players, market segments, application areas, and market growth strategies.
Key Sources Referred
- Centers for Disease Control and Prevention
- World Health Organization
- National Center for Biotechnology Information
- The Lancet
- National Perinatal Epidemiology and Statistics Unit (NPESU)
- Science Direct
- Health Resources and Services Administration (HRSA)
- Department of Health and Human Services (HHS)
- National Institutes of Health (NIH)
Animal Stem Cell Therapy Market Report Highlights
| Aspects | Details |
 Market Size By 2033 | USD 440.0 Million |
 Growth Rate | CAGR of 5.6% |
 Forecast period | 2024 - 2033 |
 Report Pages | 260 |
 By Type |
|
 By Species |
|
 By End User |
|
 By Region |
|
 Key Market Players | Regeneus Ltd., Magellan Stem Cells, Boehringer Ingelheim, MediVet Biologics LLC, VetStem, Inc., Cell Therapy Sciences, VETherapy Corporation, PrimeGen Biotech, LLC, Vetbiologics, Aratana Therapeutics, Inc. |
The total market value of animal stem cell therapy market is $256 million in 2023.
The market value of animal stem cell therapy market in 2033 is $440 million.
The base year is 2023 in animal stem cell therapy market.
The forecast period for animal stem cell therapy market is 2024 to 2033.
Animal stem cell therapy involves the use of stem cells to treat or prevent diseases in animals.
The Aratana Therapeutics, Inc., VetStem, Inc., Regeneus Ltd., Magellan Stem Cells, PrimeGen Biotech, LLC, Vetbiologics, Boehringer Ingelheim held a high market position in 2023.
The growth of the animal stem cell therapy market is driven by increasing awareness and adoption of advanced veterinary treatments, rising prevalence of chronic diseases in pets, and advancements in stem cell research and technology.
Loading Table Of Content...
